First report of Enterobacter hormaechei with respiratory disease in calves

BMC Veterinary Research

Table 1 The results of drug sensitive test

Name	Sensitivity	Diameter		Name	Sensitivity	Diameter
Name	Sensitivity	HN447	HN449	Name	Sensitivity	HN447	HN449
Penicillin G	R	0	0	Tetracycline	R	0	0
Ampicillin	R	0	0	Doxycycline	R	0	0
Cephalexin	R	0	0	Minocycline	S/I	18	15
Amoxicillin	R	0	0	Fosfomycin	S	17	20
Ciprofloxacin	S	25	24	Nitrofurantion	S	20	22
Enrofloxacin	S	26	30	Rifampin	R	0	0
Norfloxacin	S	23	30	Azithromycin	R	0	0
Levofloxacin	S	32	28	Metronidazole	R	0	0
Lomefloxacin	S	28	30	Clarithromycin	R	0	0
Lincomycin	R	0	0	Florfenicol	S	25	25
Kanamycin	I/S	17	20	Trimethoprim sulfamethoxazole	S	24	28
Gentamicin	I	14	14	Trimethoprim	S	23	27
Roxithromycin	R	0	0	Vancomycin	R	0	0

R Resistant, I Intermediate sensitivity, S Sensitive, Diameter Diameter of inhibitive zone (mm). The zone diameter (mm) interpretive criteria for drugs: Penicillin G, Ampicillin and Amoxicillin: S ≥ 17, I:14–16, R ≤ 13; Ciprofloxacin: S ≥ 15, R ≤ 14; Enrofloxacin and Lomefloxacin: S ≥ 22, I:19–21, R ≤ 18; Norfloxacin: S ≥ 17, I:13–16, R ≤ 12; Levofloxacin: S ≥ 17, I:14–16, R ≤ 13; Lincomycin: S ≥ 13, R ≤ 12; Kanamycin: S ≥ 18, I:14–17, R ≤ 13; Gentamicin: S ≥ 15, I:13–14, R ≤ 12; Roxithromycin: S ≥ 13, R ≤ 12; Tetracycline: S ≥ 15, I:12–14, R ≤ 11; Doxycycline: S ≥ 14, I:11–13, R ≤ 10; Minocycline: S ≥ 16, I:13–15, R ≤ 12; Fosfomycin: S ≥ 16, I:13–15, R ≤ 12; Nitrofurantion: S ≥ 17, I:15–16, R ≤ 14; Rifampin: S ≥ 20, I:17–19, R ≤ 16; Azithromycin: S ≥ 21, I:18–20, R ≤ 17; Metronidazole: S ≥ 17, I:14–16, R ≤ 13; Clarithromycin: S ≥ 21, I:18–20, R ≤ 17; Florfenicol: S ≥ 22, I:19–21, R ≤ 18; Trimethoprim sulfamethoxazole: S ≥ 16, I:11–15, R ≤ 10; Trimethoprim: S ≥ 16, I:11–15, R ≤ 10; Vancomycin: S ≥ 16, I:4–8, R ≤ 2

ISSN: 1746-6148